Search bioRxiv⌕ Search

bioRxiv · 10.1101/2022.12.26.520413

Head motion correction shapes functional network estimates: evidence from healthy and Parkinson's disease cohorts

Abstract

An open discussion in studies of intrinsic brain functional connectivity is the mitigation of head motion-related artifacts, particularly in the presence of peculiar symptomatology such as in Parkinsons disease (PD). Previous studies show that Independent Component Analysis (ICA) denoising improves the reproducibility of functional connectivity findings by detecting sources of non-neural signals. However, there is still no consensus about which pre-processing pipeline should be applied in natural high motion populations such as PD, particularly in relation to novel functional network descriptions derived from dynamic connectivity analyses. In this study, we investigated how different pre-processing pipelines affect intrinsic brain connectivity metrics, both static and dynamic, derived from a group of young healthy controls (HC) and a group of PD participants. A total of 20 HC and 20 PD subjects participated in this 3 T MRI study. Resting-state functional MRI images were used to test the effects of the pre-processing pipeline of static (sFC) and temporal-varying functional connectivity (dFC) estimations. Both MRI datasets were pre-processed using three different workflows differing in the motion correction approach: (i) standard motion realignment (mc); (ii) motion outlier detection and deweighting based on image intensity change estimations (DVARS) and (iii) ICA-based noise removal using reference noise features (AROMA). Furthermore, the PD dataset was also processed with a fourth method by applying an ICA-based denoising (FIX), previously trained on the HC group. sFC analysis was performed using Group ICA, by temporally concatenating different pre-processing types in pairs of different runs. Two types of dFC analyses were considered: innovation-driven co-activation patterns (iCAPs) and co-activation patterns (CAPs). CAPs allow dFC estimations that do not require the deconvolution of the hemodynamic response function and its derivative, thus potentially being less sensitive to head-motion related noise. We found that regardless of substantial head motion differences in the two groups, sFC results were consistent across denoising strategies. Conversely, dFC was extremely sensitive to denoising strategies, particularly for the PD group with the transient-based dFC analyses. Indeed, the use of the peak-based dFC framework enables the detection of time-varying networks but in a way that is highly dependent on the motion correction pipeline. In conclusion, we show that dynamic functional network representations are highly sensitive to both head motion and to fMRI denoising methods. These findings stress the importance of considering and reporting these experimental aspects to help with the reproducibility and interpretation of different studies. Future work is needed to further investigate transient-based dFC strategies that are more robust to head motion.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Saviola, F., Tambalo, S., Cabalo, D. G., Novello, L., Pierotti, E., Rabini, G., Dodich, A., Turella, L., Van De Ville, D., Jovicich, J.. 2022-12-27. Head motion correction shapes functional network estimates: evidence from healthy and Parkinson's disease cohorts. https://doi.org/10.1101/2022.12.26.520413

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗